Levofolinate Sodium

What is Levofolinate Sodium?

Levofolinate Sodium is the active (6S)-diastereoisomer of folinic acid, also known as leucovorin. It is a reduced form of folic acid and plays a crucial role in various cellular metabolic processes, particularly in DNA synthesis and repair. Unlike folic acid, levofolinate does not require enzymatic reduction to become biologically active, making it readily available for the body's metabolic needs. This medication is primarily used as an adjunct in cancer chemotherapy, either to enhance the effectiveness of certain cytotoxic drugs or to mitigate their toxic side effects. It also finds application in the treatment of specific types of folate deficiencies.

How Does it Work?

The mechanism of action of Levofolinate Sodium is multifaceted, depending on its therapeutic application. As a reduced folate, it is converted intracellularly into 5,10-methylenetetrahydrofolate, a crucial cofactor for the enzyme thymidylate synthase. This enzyme is essential for the de novo synthesis of pyrimidines, particularly thymidylate, which is a building block of DNA.

• In combination with Fluorouracil: When used with the chemotherapeutic agent fluorouracil (5-FU), Levofolinate Sodium enhances 5-FU's cytotoxic activity. It stabilizes the binding of 5-FU's active metabolite (FdUMP) to thymidylate synthase, thereby forming a ternary complex that potently inhibits the enzyme. This inhibition prevents DNA synthesis and repair in rapidly dividing cancer cells, leading to their death.
• As a 'Leucovorin Rescue' for Methotrexate Toxicity: Following high-dose methotrexate therapy, Levofolinate Sodium is administered to protect healthy cells from the severe antifolate effects of methotrexate. Methotrexate inhibits dihydrofolate reductase, an enzyme necessary for converting dihydrofolate into tetrahydrofolate. By providing an exogenous source of reduced folate, Levofolinate Sodium bypasses the inhibited enzyme, allowing healthy cells to continue DNA and RNA synthesis and repair, thus mitigating methotrexate toxicity without compromising the anticancer effect on tumor cells (which typically accumulate more methotrexate).
• In Folate Deficiency: In cases of severe folate deficiency, particularly when oral folic acid is not effective or feasible, Levofolinate Sodium can directly replenish the body's reduced folate stores, supporting normal erythropoiesis and other metabolic functions.

Medical Uses

Levofolinate Sodium is a versatile medication with several important medical applications, primarily within oncology and hematology:

• Chemotherapy Adjuvant: It is widely used in combination with fluorouracil for the treatment of various cancers, most notably colorectal cancer. This combination therapy has been shown to improve response rates and overall survival compared to fluorouracil alone. It may also be used in other gastrointestinal cancers.
• Methotrexate Rescue Therapy: This is a critical application where Levofolinate Sodium is administered after high-dose methotrexate treatment for conditions such as osteosarcoma, acute lymphoblastic leukemia, lymphoma, and some solid tumors. The goal is to prevent or reduce severe methotrexate-induced side effects like myelosuppression, mucositis, and renal toxicity. It is also used to counteract inadvertent methotrexate overdose.
• Treatment of Folate Deficiency: In specific circumstances where patients cannot adequately metabolize or absorb folic acid, or in cases of severe megaloblastic anemia due to folate deficiency, Levofolinate Sodium can be used to restore normal folate levels. This is particularly relevant for patients with genetic defects in folate metabolism or those undergoing dialysis.

Dosage

The dosage of Levofolinate Sodium is highly individualized and depends significantly on the specific medical condition being treated, the patient's overall health, and any concurrent therapies. It is typically administered intravenously, although oral formulations exist for certain indications. For chemotherapy potentiation with fluorouracil, dosages and administration schedules are precisely defined within specific chemotherapy regimens, often involving a continuous infusion or bolus injection. For methotrexate rescue, administration typically begins within 24 hours after methotrexate infusion and continues until methotrexate plasma levels fall below a safe threshold, often guided by therapeutic drug monitoring. Doses can vary widely, from a few milligrams to hundreds of milligrams per day. It is crucial that Levofolinate Sodium is administered under the strict supervision of a healthcare professional experienced in chemotherapy and supportive care, as incorrect dosing can have severe consequences, either by reducing the efficacy of chemotherapy or failing to prevent toxicity.

Side Effects

When administered alone, Levofolinate Sodium is generally well-tolerated, and direct side effects are uncommon. Most adverse reactions observed during its use are attributable to the co-administered cytotoxic agents, particularly fluorouracil or methotrexate. However, some side effects directly associated with Levofolinate Sodium can occur:

• Allergic Reactions: Rare cases of hypersensitivity reactions, including rash, itching, urticaria, and anaphylaxis, have been reported.
• Gastrointestinal Disturbances: Nausea, vomiting, and diarrhea can occur, though these are more frequently associated with co-administered chemotherapy. When used with fluorouracil, Levofolinate Sodium can exacerbate fluorouracil's gastrointestinal toxicities, leading to more severe diarrhea and mucositis (inflammation of the mucous membranes).
• Neurological Effects: Infrequently, insomnia, agitation, and depression have been noted.
• Fever: Transient fever can occur after administration.

Patients receiving Levofolinate Sodium, especially in combination with other chemotherapy drugs, are closely monitored for signs of toxicity. Prompt reporting of any unusual symptoms to a healthcare provider is essential.

Drug Interactions

Levofolinate Sodium has several significant drug interactions, primarily due to its role in folate metabolism and its use with potent cytotoxic agents:

• Fluorouracil: This is a deliberate interaction designed to enhance the cytotoxic effect of fluorouracil. However, it also significantly increases the toxicity of fluorouracil, particularly gastrointestinal side effects like severe diarrhea and mucositis, as well as myelosuppression.
• Methotrexate: Levofolinate Sodium directly antagonizes the effects of methotrexate. While this is the basis of 'rescue' therapy, improper timing or dosing can either reduce methotrexate's anticancer efficacy or fail to prevent its toxicity.
• Antiepileptic Drugs: Levofolinate Sodium may decrease the plasma concentrations of certain antiepileptic drugs, such as phenytoin, phenobarbital, and primidone. This interaction can potentially lead to an increase in seizure frequency. Patients receiving these medications concurrently should be closely monitored, and antiepileptic drug levels may need to be adjusted.
• Trimethoprim and Pyrimethamine: These are antifolate antimicrobials. While Levofolinate Sodium can theoretically interfere with their action, this interaction is less pronounced and clinically significant than with folic acid, and may even be used to mitigate their hematological toxicity in some cases.

It is crucial for healthcare providers to review a patient's complete medication list to avoid potentially harmful interactions.

FAQ

Q: Is Levofolinate Sodium the same as folic acid?

A: No, Levofolinate Sodium is not the same as folic acid. Folic acid is a synthetic form of vitamin B9, which requires enzymatic reduction in the body to become biologically active. Levofolinate Sodium, on the other hand, is an active, reduced form of folate (specifically, the active (6S)-isomer of folinic acid or leucovorin) and is directly available for metabolic pathways without needing further conversion. This makes it particularly useful in situations where folic acid metabolism might be impaired.

Q: Why is Levofolinate Sodium used in cancer treatment?

A: It serves two main purposes in cancer treatment. Firstly, it enhances the effectiveness of certain chemotherapy drugs like fluorouracil by stabilizing their binding to a crucial enzyme (thymidylate synthase), thereby increasing their ability to kill cancer cells. Secondly, it acts as a 'rescue' agent after high-dose methotrexate therapy, protecting healthy cells from the severe toxic effects of methotrexate while allowing the chemotherapy to target cancer cells.

Q: Can I take Levofolinate Sodium orally?

A: While oral formulations of Levofolinate Sodium exist, it is most commonly administered intravenously in clinical settings, especially for its use as a chemotherapy adjunct or for methotrexate rescue. Oral forms are more typically reserved for specific types of folate deficiency or as a continuation of therapy after initial intravenous administration, depending on the patient's condition and the specific therapeutic goal.

Q: What is the difference between Levofolinate Sodium and Leucovorin?

A: Leucovorin (also known as folinic acid) is a racemic mixture, meaning it contains both the active (6S)-diastereoisomer and the inactive (6R)-diastereoisomer. Levofolinate Sodium is the pure, active (6S)-diastereoisomer. This means Levofolinate Sodium is a more potent and purified form of leucovorin, potentially offering more predictable pharmacokinetics and requiring lower doses for equivalent therapeutic effects.

Products containing Levofolinate Sodium are available through trusted online pharmacies. You can browse Levofolinate Sodium-based medications at ShipperVIP or Medicenter.

Summary

Levofolinate Sodium is a critical medication in modern oncology and hematology, distinguished by its unique role as an active, reduced folate. Its primary applications include enhancing the cytotoxic effects of fluorouracil in various cancers and providing essential protection against the severe toxicities of high-dose methotrexate therapy. Furthermore, it serves as an effective treatment for specific types of folate deficiency. While generally well-tolerated on its own, its use necessitates careful management due to its significant interactions with other potent medications. Administered under strict medical supervision, Levofolinate Sodium remains an indispensable tool for optimizing cancer treatment outcomes and managing related adverse effects, underscoring its importance in patient care.